There were 1,773 press releases posted in the last 24 hours and 442,617 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for FT 218 for the Treatment of Narcolepsy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image